The evolution of secondary metabolism - a unifying model

被引:146
作者
Firn, RD [1 ]
Jones, CG
机构
[1] Univ York, Dept Biol, York YO1 5DD, N Yorkshire, England
[2] Inst Ecosyst Studies, Millbrook, NY 12545 USA
关键词
D O I
10.1046/j.1365-2958.2000.02098.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Why do microbes make secondary products? That question has been the subject of intense debate for many decades. There are two extreme opinions. Some argue that most secondary metabolites play no role in increasing the fitness of an organism, The opposite view, now widely held, is that every secondary metabolite is made because it possesses (or did possess at some stage in evolution) a biological activity that endows the producer with increased fitness. These opposing views can be reconciled by recognizing that, because of the principles governing molecular interactions, potent biological activity is a rare property for any molecule to possess. Consequently, in order for an organism to evolve the rare potent, biologically active molecule, a great many chemical structures have to be generated, most of which will possess no useful biological activity. Thus, the two sides of the debate about the role and evolution of secondary metabolism can be accommodated within the view that the possession of secondary metabolism can enhance fitness, but that many products of secondary metabolism will not enhance the fitness of the producer. It is proposed that secondary metabolism will have evolved such that traits that optimize the production and retention of chemical diversity at minimum cost will have been selected. Evidence exists for some of these predicted traits. Opportunities now exist to exploit these unique properties of secondary metabolism to enhance secondary product diversity and to devise new strategies for biotransformation and bioremediation.
引用
收藏
页码:989 / 994
页数:6
相关论文
共 25 条
[1]   SUBSTRATE-SPECIFICITY OF L-DELTA-(ALPHA-AMINOADIPOYL)-L-CYSTEINYL-D-VALINE SYNTHETASE FROM CEPHALOSPORIUM-ACREMONIUM - DEMONSTRATION OF THE STRUCTURE OF SEVERAL UNNATURAL TRIPEPTIDE PRODUCTS [J].
BALDWIN, JE ;
SHIAU, CY ;
BYFORD, MF ;
SCHOFIELD, CJ .
BIOCHEMICAL JOURNAL, 1994, 301 :367-372
[2]   PENICILLIN BIOSYNTHESIS - MULTIPLE PATHWAYS FROM A MODIFIED SUBSTRATE [J].
BALDWIN, JE ;
ADLINGTON, RM ;
DEROME, AE ;
TING, HH ;
TURNER, NJ .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1984, (18) :1211-1214
[3]   FROM MOLECULAR-GENETICS AND SECONDARY METABOLISM TO MOLECULAR METABOLITES AND SECONDARY GENETICS [J].
BENNETT, JW .
CANADIAN JOURNAL OF BOTANY-REVUE CANADIENNE DE BOTANIQUE, 1995, 73 :S917-S924
[4]  
BERENBAUM MR, 1996, RECENT ADV PHYTOCHEM, P1
[5]   The mechanism of ACV synthetase [J].
Byford, MF ;
Baldwin, JE ;
Shiau, CY ;
Schofield, CJ .
CHEMICAL REVIEWS, 1997, 97 (07) :2631-2649
[6]   THE GENETICS OF CHEMICAL DIVERSITY [J].
CERDAOLMEDO, E .
CRITICAL REVIEWS IN MICROBIOLOGY, 1994, 20 (02) :151-160
[7]   BIOCHEMICAL-CHARACTERIZATION OF A SPEARMINT MUTANT THAT RESEMBLES PEPPERMINT IN MONOTERPENE CONTENT [J].
CROTEAU, R ;
KARP, F ;
WAGSCHAL, KC ;
SATTERWHITE, DM ;
HYATT, DC ;
SKOTLAND, CB .
PLANT PHYSIOLOGY, 1991, 96 (03) :744-752
[8]  
DEMAIN AL, 1995, YEARS ANTIMICROBIALS, P205
[9]  
Firn RD, 1996, RECENT ADV PHYTOCHEM, V30, P295
[10]   Secondary metabolism and the risks of GMOs [J].
Firn, RD ;
Jones, CG .
NATURE, 1999, 400 (6739) :13-14